Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17418375 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418871 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418740 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418241 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418513 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418765 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418824 | 0.98 | CA1 (0.36) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418544 | 0.97 | CA1 (0.37) | CA1TSHRALDH1A1BBOX1GPR84 | |
| SCHEMBL17418436 | 0.94 | CA1 (0.39) | CA1ALDH1A1BBOX1GPR84FOLH1 | |
| SCHEMBL17418889 | 0.94 | CA1 (0.39) | CA1ALDH1A1BBOX1GPR84FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10087155-B2 | Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2018-10-02 | — | — | US | disclosed |
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | CEL, CROCC, ALG1 | CA1 1524/4885TSHR 4776/4885ALDH1A1 4797/4885 |
| US-10087155-B2 | Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method | CEL, CROCC, ALG1 | CA1 1524/4885TSHR 4776/4885ALDH1A1 4797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.